Published in J Am Coll Cardiol on November 15, 2000
Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects. Circ Heart Fail (2011) 1.39
Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation (2012) 1.11
Mitochondria in the human heart. J Bioenerg Biomembr (2009) 1.03
Potential mechanisms of low-sodium diet-induced cardiac disease: superoxide-NO in the heart. Circ Res (2009) 0.83
The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly. Heart Fail Rev (2012) 0.82
Heart failure in remission for more than 13 years after removal of a left ventricular assist device. Tex Heart Inst J (2014) 0.78
Molecular- and organelle-based predictive paradigm underlying recovery by left ventricular assist device support. Circ Heart Fail (2014) 0.78
Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning. JACC Basic Transl Sci (2016) 0.77
Cellular, molecular, genomic changes occurring in the heart under mechanical circulatory support. Ann Cardiothorac Surg (2014) 0.75
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24
Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation (1997) 4.54
Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res (2001) 2.89
Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg (2001) 2.80
Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res (1994) 2.64
Quantitative analysis of reproducible changes in high-voltage electrophotography. J Altern Complement Med (2001) 2.29
Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res (1998) 2.16
Implantable left ventricular assist devices. N Engl J Med (1998) 2.07
Stretch-induced programmed myocyte cell death. J Clin Invest (1995) 1.99
Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg (1995) 1.96
Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg (1998) 1.95
Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation (1998) 1.90
Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest (1996) 1.81
A regional survey of health insurance coverage for complementary and alternative medicine: current status and future ramifications. J Altern Complement Med (2001) 1.77
Surgical management of valvular disease in patients requiring left ventricular assist device support. Ann Thorac Surg (2001) 1.68
Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr (2001) 1.67
Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg (2000) 1.65
Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino) (1997) 1.64
Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg (1995) 1.63
Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg (1998) 1.58
Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res (1994) 1.57
Long-term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years. J Pediatr (1997) 1.57
The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation (1995) 1.56
ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation (1997) 1.56
cAMP signal transduction cascade, a novel pathway for the regulation of endothelial nitric oxide production in coronary blood vessels. Arterioscler Thromb Vasc Biol (2001) 1.55
Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation (1995) 1.49
The effects of self-hypnosis on quality of life following coronary artery bypass surgery: preliminary results of a prospective, randomized trial. J Altern Complement Med (1995) 1.49
Preservation of anterior leaflet chordae tendineae during mitral valve replacement. Ann Thorac Surg (1994) 1.47
Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg (1997) 1.47
Acute pulmonary embolism in pediatric patients awaiting heart transplantation. J Am Coll Cardiol (1991) 1.43
Surgical management of cardiac pheochromocytoma. Resection versus transplantation. Ann Surg (1995) 1.42
Pediatric cardiac transplantation using hearts previously refused for quality: a single center experience. Am J Transplant (2013) 1.41
Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg (1994) 1.40
Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass. Crit Care Med (2000) 1.40
Discrepancy between claimed field flux density of some commercially available magnets and actual gaussmeter measurements. Altern Ther Health Med (2001) 1.39
Inhaled nitric oxide is not a myocardial depressant in a porcine model of heart failure. J Thorac Cardiovasc Surg (1998) 1.39
Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation (2000) 1.32
Surgical management of the patient with an implanted cardiac device: implications of electromagnetic interference. Ann Surg (1999) 1.28
Experience with heart transplantation for cardiac tumors. J Heart Lung Transplant (1995) 1.28
Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension (1995) 1.26
Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation (1995) 1.26
Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med (1997) 1.24
Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation (1995) 1.24
Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation (2000) 1.21
Novel technique to repair type A acute aortic dissection in patients with a left ventricular assist device. Ann Thorac Surg (2001) 1.21
A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation (1997) 1.20
Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure. Circ Res (2001) 1.19
Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ Res (1993) 1.16
Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res (1996) 1.16
Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg (1999) 1.16
Reactive dilation of large coronary arteries in conscious dogs. Circ Res (1984) 1.15
Early progressive mobilization of patients with left ventricular assist devices is safe and optimizes recovery before heart transplantation. J Heart Lung Transplant (1996) 1.14
Optimal timing of revascularization: transmural versus nontransmural acute myocardial infarction. Ann Thorac Surg (2001) 1.14
De novo solid malignancies after cardiac transplantation. Ann Thorac Surg (1995) 1.13
Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation (2006) 1.12
Changes in type I collagen following laser welding. Lasers Surg Med (1992) 1.12
Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circ Res (1996) 1.12
A randomized trial of antithrombin concentrate for treatment of heparin resistance. Ann Thorac Surg (2000) 1.11
Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart. Proc Natl Acad Sci U S A (2001) 1.10
Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest (1994) 1.10
Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation (1994) 1.09
Hepatobiliary complications of polyarteritis nodosa. Arch Surg (1991) 1.09
Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res (1996) 1.09
Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. Circ Res (1999) 1.09
Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxynitrite. Am J Physiol (1994) 1.08
Failure to express the P-selectin gene or P-selectin blockade confers early pulmonary protection after lung ischemia or transplantation. Proc Natl Acad Sci U S A (1997) 1.08
Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg (2000) 1.08
Use of alternative medicine by patients undergoing cardiac surgery. J Thorac Cardiovasc Surg (2000) 1.04
Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine. Arterioscler Thromb Vasc Biol (2003) 1.04
Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation (1998) 1.04
Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs. Am J Physiol Heart Circ Physiol (2000) 1.03
Role of endothelium-derived nitric oxide in the regulation of cardiac oxygen metabolism: implications in health and disease. Circ Res (2000) 1.03
Nitric oxide modulates mitochondrial respiration in failing human heart. Circulation (1999) 1.03
The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant (1997) 1.03
Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest (1995) 1.02
100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Ann Thorac Surg (1999) 1.01
Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation (1998) 1.01
24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization. J Am Coll Cardiol (1993) 1.01
Nitric oxide controls cardiac substrate utilization in the conscious dog. Cardiovasc Res (1999) 1.01
Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation (1999) 1.01
Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance. J Heart Lung Transplant (1999) 1.00
The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci U S A (1994) 0.99
Nitric oxide production and NO synthase gene expression contribute to vascular regulation during exercise. Med Sci Sports Exerc (1995) 0.99
Delayed enhanced nitric oxide-mediated coronary vasodilation following brief ischemia and prolonged reperfusion in conscious dogs. Circ Res (1997) 0.99
Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation (2001) 0.98
Radical excisional therapy and total cardiac transplantation for recurrent atrial myxoma. Ann Thorac Surg (1995) 0.97
Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. J Am Coll Cardiol (1997) 0.96
Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet (1999) 0.96
Development of decompensated dilated cardiomyopathy is associated with decreased gene expression and activity of the milrinone-sensitive cAMP phosphodiesterase PDE3A. Circulation (1997) 0.96
Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res (1998) 0.96
Duration of left ventricular assist device support affects transplant survival. J Heart Lung Transplant (1996) 0.95
Endogenous nitric oxide in the control of skeletal muscle oxygen extraction during exercise. Acta Physiol Scand (2000) 0.95
Amlodipine promotes kinin-mediated nitric oxide production in coronary microvessels of failing human hearts. Am J Cardiol (1999) 0.95
Long-term survival after cardiac retransplantation: a twenty-year single-center experience. J Thorac Cardiovasc Surg (1999) 0.95
Left ventricular volume reduction surgery for heart failure: a physiologic perspective. J Thorac Cardiovasc Surg (2001) 0.94
Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass. J Thorac Cardiovasc Surg (1998) 0.94
Fungal left ventricular assist device endocarditis. Ann Thorac Surg (2001) 0.94
Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant (1998) 0.94